A Clinical Trial to Evaluate Effect of IBB0979 in Patients With Advanced Malignant Tumors

NCT05991583 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Malignant Tumors

Interventions

DRUG: IBB0979

Sponsor

SUNHO（China）BioPharmaceutical CO., Ltd.